Atrás
Precio Unicycive Therapeutics Inc (UNCY)
Gráfico del Precio de Acciones UNCY
UNCY Dividendos
Unicycive Therapeutics Inc
$6.19
-1.27%
$-0.07
Al cierre: Jan 16, 16:00:00 GMT-5
$6.18
-0.16%
$-0.01
Mercado Previo: Jan 20, 07:58:52 GMT-5
Estadísticas clave
Cierre Anterior
$6.27
Precio de apertura
$6.27
Rango del día
$6.01 - $6.3
Rango de 52 semanas
$3.71 - $11
Volumen
582.3K
Volumen promedio
436.7K
EPS (TTM)
-2.01
Rendimiento de dividendos
--
Cap. de mercado
$132.8M
¿Qué es UNCY?
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. The company is headquartered in Los Altos, California and currently employs 22 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
